000 | 01905 a2200553 4500 | ||
---|---|---|---|
005 | 20250515175043.0 | ||
264 | 0 | _c20091207 | |
008 | 200912s 0 0 eng d | ||
022 | _a1569-8041 | ||
024 | 7 |
_a10.1093/annonc/mdp053 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan de Schans, S A M | |
245 | 0 | 0 |
_aValidation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting. _h[electronic resource] |
260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cOct 2009 |
||
300 |
_a1697-702 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aCardiovascular Diseases _xcomplications |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHemoglobins _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
650 | 0 | 4 |
_aLymph Nodes _xpathology |
650 | 0 | 4 |
_aLymphoma, Follicular _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aModels, Statistical |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNetherlands _xepidemiology |
650 | 0 | 4 | _aPopulation Groups |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aRegression Analysis |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aSteyerberg, E W | |
700 | 1 | _aNijziel, M R | |
700 | 1 | _aCreemers, G-J | |
700 | 1 | _aJanssen-Heijnen, M L | |
700 | 1 | _avan Spronsen, D J | |
773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 20 _gno. 10 _gp. 1697-702 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdp053 _zAvailable from publisher's website |
999 |
_c18967404 _d18967404 |